In both normal and BCNS fibroblasts samples, upstream regulators CDKN1A and TP53 were activated whereas the E2F1 and RABL6 were predicted to be inhibited in response to rapamycin. This evidence concerns the gene TP53 and nevoid basal cell carcinoma syndrome.